- Home
- CCJ vs WAT Comparison
CCJ vs WAT Comparison
Compare CCJ & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCJ
- WAT
- Stock Information
- Founded
- CCJ 1987
- WAT 1958
- Country
- CCJ Canada
- WAT United States
- Employees
- CCJ N/A
- WAT N/A
- Industry
- CCJ Other Metals and Minerals
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- CCJ Basic Materials
- WAT Industrials
- Exchange
- CCJ Nasdaq
- WAT Nasdaq
- Market Cap
- CCJ 34.0B
- WAT 17.8B
- IPO Year
- CCJ N/A
- WAT 1995
- Fundamental
- Price
- CCJ $80.61
- WAT $296.01
- Analyst Decision
- CCJ Strong Buy
- WAT Hold
- Analyst Count
- CCJ 4
- WAT 14
- Target Price
- CCJ $91.32
- WAT $374.07
- AVG Volume (30 Days)
- CCJ 3.7M
- WAT 586.5K
- Earning Date
- CCJ 11-06-2025
- WAT 10-31-2025
- Dividend Yield
- CCJ 0.15%
- WAT N/A
- EPS Growth
- CCJ 106.70
- WAT 10.77
- EPS
- CCJ 0.89
- WAT 11.09
- Revenue
- CCJ $2,617,729,824.00
- WAT $3,046,056,000.00
- Revenue This Year
- CCJ $10.63
- WAT $7.19
- Revenue Next Year
- CCJ $2.48
- WAT $6.40
- P/E Ratio
- CCJ $86.84
- WAT $26.65
- Revenue Growth
- CCJ 34.69
- WAT 5.89
- 52 Week Low
- CCJ $35.00
- WAT $275.05
- 52 Week High
- CCJ $83.02
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- CCJ 60.69
- WAT 48.32
- Support Level
- CCJ $77.53
- WAT $294.96
- Resistance Level
- CCJ $81.58
- WAT $303.24
- Average True Range (ATR)
- CCJ 2.93
- WAT 8.69
- MACD
- CCJ 0.38
- WAT 0.33
- Stochastic Oscillator
- CCJ 77.90
- WAT 39.90
About CCJ Cameco Corporation
Cameco Corp is a provider of uranium needed to generate clean, reliable baseload electricity around the globe. one of those uranium producers. It has three reportable segments, Uranium, Fuel Services, and Westinghouse. It derives maximum revenue from the Westinghouse Segment. It has some projects namely; Millennium, Yeelirrie, Kintyre, and Exploration. The company operates in Canada, Kazakhstan, Germany, Australia, and the United States.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.